Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jared Boyd"'
Autor:
Jared Boyd, James. P Mackey
Integration with the vessel Automation and Control system is a critical milestone in a Ballast Water Treatment System (BWTS) retrofit project. When completed properly, it provides for simple and intuitive operation of the BWTS and supports compliance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01cb05858cff28bf9a5b0b91bcfd718c
https://zenodo.org/record/1456732
https://zenodo.org/record/1456732
Publikováno v:
Journal of Clinical Anesthesia. 25:348-350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b04b6f07387dac894368cd793c526d
https://doi.org/10.1016/j.jclinane.2013.02.002
https://doi.org/10.1016/j.jclinane.2013.02.002
Autor:
Tobin Strom, Uwe Christians, Jared Boyd, Manuel Haschke, Peter Marbach, Mark Roberts, Lili Arabshahi
Publikováno v:
Therapeutic drug monitoring. 29(6)
Everolimus is an immunosuppressant used as rejection prophylaxis in patients undergoing transplants. It requires blood concentration-guided dosing and is extensively metabolized. It was the goal to assess the crossreactivity of the major everolimus m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bfaadb1127e8623e18d59e9fe7cb4bd
https://pubmed.ncbi.nlm.nih.gov/18043471
https://pubmed.ncbi.nlm.nih.gov/18043471
Publikováno v:
Clinical biochemistry. 39(7)
Objectives: This study compared the performance of a fluorescent polarization immunoassay (FPIA) against HPLC-tandem mass spectrometry (HPLC-MS) for the measurement of everolimus in renal transplant recipients. Design and methods: A total of 333 pre-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008845914f34465e60962544eafd0e2f
https://pubmed.ncbi.nlm.nih.gov/16725133
https://pubmed.ncbi.nlm.nih.gov/16725133
Publikováno v:
Therapeutic Drug Monitoring. 27:251-252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8e1b5656c9c7aeb0ad1058870207b9f
https://doi.org/10.1097/00007691-200504000-00173
https://doi.org/10.1097/00007691-200504000-00173
Publikováno v:
Therapeutic Drug Monitoring. 27:213-214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80839a1929b97f659308082cd94cfc98
https://doi.org/10.1097/00007691-200504000-00029
https://doi.org/10.1097/00007691-200504000-00029
Publikováno v:
Therapeutic Drug Monitoring. 27:258
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4254c565aa86ba9100ce669262c1eee6
https://doi.org/10.1097/00007691-200504000-00198
https://doi.org/10.1097/00007691-200504000-00198
Publikováno v:
Therapeutic Drug Monitoring. 27:215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec05f319aca50cb54bdd67395f1f8c53
https://doi.org/10.1097/00007691-200504000-00035
https://doi.org/10.1097/00007691-200504000-00035
Publikováno v:
Therapeutic Drug Monitoring. 27:243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1499b1e3d3f5489c4d98a8f2549db90d
https://doi.org/10.1097/00007691-200504000-00140
https://doi.org/10.1097/00007691-200504000-00140
Publikováno v:
Therapeutic Drug Monitoring. 27:215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c769b5af649b9b857a785accba281f7
https://doi.org/10.1097/00007691-200504000-00036
https://doi.org/10.1097/00007691-200504000-00036